Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL301P is one of several hundred 7SL RNA-derived pseudogenes within the human genome. It is a truncated, non-functional genomic copy of the 7SL RNA gene, which normally encodes the RNA component of the signal recognition particle (SRP), an essential RNP complex for co-translational protein targeting to the endoplasmic reticulum[1][2][10]. Pseudogenes such as RN7SL301P do not encode protein and are typically not transcribed into functional RNA. However, in some cases, pseudogene transcripts may exert regulatory effects (for example, by acting as miRNA decoys or being processed into small interfering RNAs), but there is no evidence for a specific biological function, disease association, or therapeutic targeting of RN7SL301P itself[5][8][10]. Its closely related parent, RN7SL1 (7SL RNA), plays a well-understood structural and regulatory role, but pseudogenes such as RN7SL301P are generally considered genomic fossils or, at most, non-coding RNA regulators, and are not recognized as therapeutic targets. Key clarifications: - RN7SL301P is a pseudogene, not a gene encoding a functional protein, receptor, or enzyme and is not a therapeutic target[1][2][10]. - No approved drugs, biomarkers, or disease roles are directly assigned to this specific pseudogene[1][2]. - The entry is likely not a valid molecular target; if a therapeutic target related to 7SL RNA or the SRP is intended, RN7SL1 or components of the SRP complex should be searched instead[4][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 301, pseudogene (RN7SL301P).